Hepion Pharmaceuticals Inc (NASDAQ: HEPA): The Best-Of-Breed For Investing?
Currently, there are 10.62M common shares owned by the public and among those 10.57M shares have been available to trade. Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, […]
Hepion Pharmaceuticals Inc (NASDAQ: HEPA): Do Not Miss The Gain Train
Hepion Pharmaceuticals Inc (HEPA) concluded trading on Wednesday at a closing price of $0.17, with 5.77 million shares of worth about $0.98 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -73.39% during that period and on February 19, 2025 the price saw a […]
There Is Clear Momentum For Hepion Pharmaceuticals Inc (NASDAQ: HEPA)
Hepion Pharmaceuticals Inc (HEPA) concluded trading on Wednesday at a closing price of $0.14, with 35.16 million shares of worth about $4.92 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -83.93% during that period and on January 22, 2025 the price saw a […]
